Literature DB >> 19379426

Coronary and aortic calcifications in patients new to dialysis.

David M Spiegel1, Paolo Raggi, Ravindra Mehta, Jill S Lindberg, Michel Chonchol, James Ehrlich, George James, Glenn M Chertow, Geoffrey A Block.   

Abstract

BACKGROUND: Vascular calcification has been associated with all cause and cardiovascular mortality in patients with end-stage kidney disease (ESRD). Whether vascular calcification is present in persons with advanced chronic kidney disease starting dialysis or develops in patients on dialysis is unknown. The purpose of this study was to examine the prevalence of vascular and coronary calcification in patients new to hemodialysis.
METHODS: A total of 129 subjects new to dialysis were evaluated using electron beam computed tomography. The primary outcome was the presence and extent of coronary artery, aortic, and valvular calcification.
RESULTS: Forty-three percent of subjects had no significant coronary artery calcification (total score </= 30) and 27% had no detectable aortic calcification. Thirty-four percent had coronary artery scores that placed them above the 90th percentile for age and sex. Coronary artery calcification was significantly associated with a history of coronary artery disease and atherosclerotic vascular disease (ASVD) whereas aortic calcification was significantly associated with ASVD. Age (p < 0.0001), pulse pressure (p = 0.004), diabetes mellitus (p = 0.009), and a history of smoking (p = 0.026) were independently associated with the extent of coronary artery calcification. Age (p < 0.0001) and pulse pressure (p = 0.0003) were independently associated with the extent of aortic calcification.
CONCLUSIONS: A large fraction of patients new to hemodialysis had no evidence of coronary artery or aortic calcification. Coupled with the extensive vascular calcification reported by others in prevalent dialysis patients these findings suggest that dialysis-specific factors contribute to calcific vascular disease in ESRD.

Entities:  

Year:  2004        PMID: 19379426     DOI: 10.1111/j.1492-7535.2004.01104.x

Source DB:  PubMed          Journal:  Hemodial Int        ISSN: 1492-7535            Impact factor:   1.812


  12 in total

1.  Deoxycholic Acid, a Metabolite of Circulating Bile Acids, and Coronary Artery Vascular Calcification in CKD.

Authors:  Anna Jovanovich; Tamara Isakova; Geoffrey Block; Jason Stubbs; Gerard Smits; Michel Chonchol; Makoto Miyazaki
Journal:  Am J Kidney Dis       Date:  2017-08-09       Impact factor: 8.860

Review 2.  Noninvasive imaging for assessment of calcification in chronic kidney disease.

Authors:  Cristina Karohl; Luis D'Marco Gascón; Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

3.  Effects of phosphate binders in moderate CKD.

Authors:  Geoffrey A Block; David C Wheeler; Martha S Persky; Bryan Kestenbaum; Markus Ketteler; David M Spiegel; Matthew A Allison; John Asplin; Gerard Smits; Andrew N Hoofnagle; Laura Kooienga; Ravi Thadhani; Michael Mannstadt; Myles Wolf; Glenn M Chertow
Journal:  J Am Soc Nephrol       Date:  2012-07-19       Impact factor: 10.121

4.  Prevalence of abdominal artery calcification in dialysis patients with end-stage renal disease: a systematic review and meta-analysis.

Authors:  Zhihui Yao; Congxia Wang; Qiaona Zhang; Shan Ma; Baosong Gui; Chaoyang Duan
Journal:  Int Urol Nephrol       Date:  2017-09-21       Impact factor: 2.370

5.  Phosphate binders: Sevelamer in the prevention and treatment of hyperphosphataemia in chronic renal failure.

Authors:  S Spaia
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

6.  Hypertension and hyperparathyroidism are associated with left ventricular hypertrophy in patients on hemodialysis.

Authors:  N Al-Hilali; N Hussain; A I Ataia; M Al-Azmi; B Al-Helal; K V Johny
Journal:  Indian J Nephrol       Date:  2009-10

7.  Is residual renal function and better phosphate control in peritoneal dialysis an answer for the lower prevalence of valve calcification compared to hemodialysis patients?

Authors:  Merita Rroji; Saimir Seferi; Majlinda Cafka; Elizana Petrela; Erjola Likaj; Myftar Barbullushi; Nestor Thereska; Goce Spasovski
Journal:  Int Urol Nephrol       Date:  2013-04-17       Impact factor: 2.370

Review 8.  Calcium balance and negative impact of calcium load in peritoneal dialysis patients.

Authors:  Angela Yee-Moon Wang
Journal:  Perit Dial Int       Date:  2014-02-04       Impact factor: 1.756

9.  Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD).

Authors:  Marinella Ruospo; Suetonia C Palmer; Patrizia Natale; Jonathan C Craig; Mariacristina Vecchio; Grahame J Elder; Giovanni Fm Strippoli
Journal:  Cochrane Database Syst Rev       Date:  2018-08-22

10.  Potential future uses of calcimimetics in patients with chronic kidney disease.

Authors:  Michel Chonchol; Rudolf P Wüthrich
Journal:  NDT Plus       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.